- Home
- SABS vs WNW Comparison
SABS vs WNW Comparison
Compare SABS & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- WNW
- Stock Information
- Founded
- SABS 2014
- WNW 2015
- Country
- SABS United States
- WNW China
- Employees
- SABS N/A
- WNW N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- WNW Catalog/Specialty Distribution
- Sector
- SABS Health Care
- WNW Consumer Discretionary
- Exchange
- SABS Nasdaq
- WNW Nasdaq
- Market Cap
- SABS 31.2M
- WNW 26.6M
- IPO Year
- SABS N/A
- WNW 2020
- Fundamental
- Price
- SABS $3.06
- WNW $1.65
- Analyst Decision
- SABS Strong Buy
- WNW
- Analyst Count
- SABS 3
- WNW 0
- Target Price
- SABS $9.00
- WNW N/A
- AVG Volume (30 Days)
- SABS 261.4K
- WNW 15.6K
- Earning Date
- SABS 11-06-2025
- WNW 12-04-2025
- Dividend Yield
- SABS N/A
- WNW N/A
- EPS Growth
- SABS N/A
- WNW N/A
- EPS
- SABS N/A
- WNW 9.06
- Revenue
- SABS $114,698.00
- WNW $158,485.00
- Revenue This Year
- SABS N/A
- WNW N/A
- Revenue Next Year
- SABS N/A
- WNW N/A
- P/E Ratio
- SABS N/A
- WNW $0.18
- Revenue Growth
- SABS N/A
- WNW N/A
- 52 Week Low
- SABS $1.00
- WNW $0.95
- 52 Week High
- SABS $6.60
- WNW $70.00
- Technical
- Relative Strength Index (RSI)
- SABS 59.76
- WNW 41.93
- Support Level
- SABS $2.93
- WNW $1.45
- Resistance Level
- SABS $3.34
- WNW $1.78
- Average True Range (ATR)
- SABS 0.23
- WNW 0.14
- MACD
- SABS 0.01
- WNW -0.02
- Stochastic Oscillator
- SABS 61.69
- WNW 41.61
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.